经纪商 Set Centene Co.(纽约证券交易所代码：CNC) PT 报价 95.39 美元|CNC_新浪财经

Centene Co. (NYSE:CNC – Get Rating) has earned an average rating of "Moderate Buy" from the twenty brokerages that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, nine have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $95.39.

Several research analysts recently commented on CNC shares. Credit Suisse Group lifted their price target on Centene from $104.00 to $106.00 and gave the stock an "outperform" rating in a research report on Monday, December 19th. Argus lifted their price target on Centene from $95.00 to $99.00 in a research report on Wednesday, December 14th. Loop Capital dropped their price target on Centene from $110.00 to $95.00 in a research report on Wednesday, February 8th. Morgan Stanley decreased their price objective on shares of Centene from $103.00 to $94.00 and set an "overweight" rating for the company in a research note on Thursday, March 9th. Finally, Mizuho decreased their price objective on shares of Centene from $92.00 to $80.00 and set a "neutral" rating for the company in a research note on Tuesday, February 28th.

Get

Centene

alerts:

Centene Trading Up 0.8 %

Shares of CNC stock opened at $63.65 on Thursday. The firm has a market capitalization of $35.09 billion, a PE ratio of 31.20, a PEG ratio of 0.75 and a beta of 0.56. The stock has a fifty day simple moving average of $69.86 and a two-hundred day simple moving average of $77.28. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.06 and a current ratio of 1.06. Centene has a 52-week low of $61.71 and a 52-week high of $98.53.

Centene (NYSE:CNC – Get Rating) last issued its quarterly earnings data on Tuesday, February 7th. The company reported $0.86 earnings per share for the quarter, missing analysts' consensus estimates of $0.87 by ($0.01). The firm had revenue of $35.56 billion for the quarter, compared to analysts' expectations of $35.37 billion. Centene had a net margin of 0.83% and a return on equity of 12.98%. The company's revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.01 EPS. On average, analysts predict that Centene will post 6.34 EPS for the current fiscal year.

Centene declared that its Board of Directors has approved a share repurchase program on Friday, December 16th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to reacquire up to 4.3% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its stock is undervalued.

Insider Buying and Selling

In other Centene news, CEO Sarah London acquired 30,000 shares of Centene stock in a transaction that occurred on Friday, March 17th. The stock was bought at an average price of $62.60 per share, with a total value of $1,878,000.00. Following the completion of the purchase, the chief executive officer now directly owns 313,953 shares of the company's stock, valued at approximately $19,653,457.80. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, COO James E. Murray purchased 6,750 shares of the business's stock in a transaction on Wednesday, February 8th. The shares were acquired at an average cost of $73.30 per share, with a total value of $494,775.00. Following the completion of the acquisition, the chief operating officer now owns 136,220 shares of the company's stock, valued at $9,984,926. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Sarah London purchased 30,000 shares of the business's stock in a transaction on Friday, March 17th. The stock was purchased at an average cost of $62.60 per share, for a total transaction of $1,878,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 313,953 shares of the company's stock, valued at approximately $19,653,457.80. The disclosure for this purchase can be found here. Insiders acquired 46,750 shares of company stock valued at $3,091,605 over the last 90 days. Corporate insiders own 0.28% of the company's stock.

Institutional Investors Weigh In On Centene

A number of large investors have recently made changes to their positions in CNC. Chilton Capital Management LLC purchased a new stake in shares of Centene during the second quarter valued at $25,000. Coppell Advisory Solutions Corp. purchased a new stake in Centene in the fourth quarter valued at $25,000. Whittier Trust Co. of Nevada Inc. boosted its holdings in Centene by 5,700.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 348 shares of the company's stock valued at $29,000 after purchasing an additional 342 shares during the last quarter. Compagnie Lombard Odier SCmA purchased a new stake in Centene in the fourth quarter valued at $41,000. Finally, James Investment Research Inc. purchased a new stake in Centene in the third quarter valued at $51,000. 93.28% of the stock is owned by hedge funds and other institutional investors.

Centene Company Profile

(Get Rating)

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The company was founded in 1984 and is headquartered in St. Louis, MO.